Search research articles
Contact Us
Filters
Showing results (311-320 of 327) with videos related to
Page
of 33
Sort By:
Plos Pathogens
|
March 17, 2023
Negative regulation of type I interferon signaling by integrin-linked kinase permits dengue virus replication
Yi-Sheng Kao, Li-Chiu Wang, Po-Chun Chang, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]
|
August 25, 2005
[Randomized trial of breast self-examination in 266,064 women in Shanghai]
Dao-li Gao, David B Thomas, Roberta M Ray, et al.
Journal of General Internal Medicine
|
September 11, 2021
The Longer-Term Benefits and Harms of Glucagon-Like Peptide-1 Receptor Agonists: a Systematic Review and Meta-Analysis
Jason T Alexander, Erin M Staab, Wen Wan, et al.
Journal of General Internal Medicine
|
December 1, 2021
Longer-term Benefits and Risks of Sodium-Glucose Cotransporter-2 Inhibitors in Type 2 Diabetes: a Systematic Review and Meta-analysis
Jason T Alexander, Erin M Staab, Wen Wan, et al.
Plos One
|
June 6, 2015
Healthcare- and Community-Associated Methicillin-Resistant Staphylococcus aureus (MRSA) and Fatal Pneumonia with Pediatric Deaths in Krasnoyarsk, Siberian Russia: Unique MRSA's Multiple Virulence Factors, Genome, and Stepwise Evolution
Olga E Khokhlova, Wei-Chun Hung, Tsai-Wen Wan, et al.
Microbiology and Immunology
|
July 25, 2017
Molecular characterization of Streptococcus pneumoniae, particularly serotype19A/ST320, which emerged in Krasnoyarsk, Russia
Irina N Protasova, Tsai-Wen Wan, Natalya V Bakhareva, et al.
Diabetes Care
|
September 25, 2025
Development and Internal Validation of the Multiethnic Type 2 Diabetes Outcomes Model for the U.S. (DOMUS)
Aaron N Winn, Zachary Newman, Amber Deckard, et al.
Vaccine
|
March 15, 2022
A novel chimeric dengue vaccine candidate composed of consensus envelope protein domain III fused to C-terminal-modified NS1 protein
Hong-Jyun Huang, Martyr Yang, Hsin-Wei Chen, et al.
Leukemia & Lymphoma
|
August 19, 2015
Phase 1 trial of carfilzomib (PR-171) in combination with vorinostat (SAHA) in patients with relapsed or refractory B-cell lymphomas
Beata Holkova, Maciej Kmieciak, Prithviraj Bose, et al.
Journal of Medical Virology
|
January 31, 2026
A Multivalent Dengue Fusion Protein ΔcNS1-cEDIII-ΔnNS3 Confers Cross-Serotype Protection and Durable Immunity in Mice
Mu-Fan Pi, Wei-Chiao Liao, Xin-Yan Li, et al.
Page
of 33
Search research articles
Search
Showing results (311-320 of 327) with videos related to
Sort By:
Page
of 33
Plos Pathogens
|
March 17, 2023
Negative regulation of type I interferon signaling by integrin-linked kinase permits dengue virus replication
Yi-Sheng Kao, Li-Chiu Wang, Po-Chun Chang, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]
|
August 25, 2005
[Randomized trial of breast self-examination in 266,064 women in Shanghai]
Dao-li Gao, David B Thomas, Roberta M Ray, et al.
Journal of General Internal Medicine
|
September 11, 2021
The Longer-Term Benefits and Harms of Glucagon-Like Peptide-1 Receptor Agonists: a Systematic Review and Meta-Analysis
Jason T Alexander, Erin M Staab, Wen Wan, et al.
Journal of General Internal Medicine
|
December 1, 2021
Longer-term Benefits and Risks of Sodium-Glucose Cotransporter-2 Inhibitors in Type 2 Diabetes: a Systematic Review and Meta-analysis
Jason T Alexander, Erin M Staab, Wen Wan, et al.
Plos One
|
June 6, 2015
Healthcare- and Community-Associated Methicillin-Resistant Staphylococcus aureus (MRSA) and Fatal Pneumonia with Pediatric Deaths in Krasnoyarsk, Siberian Russia: Unique MRSA's Multiple Virulence Factors, Genome, and Stepwise Evolution
Olga E Khokhlova, Wei-Chun Hung, Tsai-Wen Wan, et al.
Microbiology and Immunology
|
July 25, 2017
Molecular characterization of Streptococcus pneumoniae, particularly serotype19A/ST320, which emerged in Krasnoyarsk, Russia
Irina N Protasova, Tsai-Wen Wan, Natalya V Bakhareva, et al.
Diabetes Care
|
September 25, 2025
Development and Internal Validation of the Multiethnic Type 2 Diabetes Outcomes Model for the U.S. (DOMUS)
Aaron N Winn, Zachary Newman, Amber Deckard, et al.
Vaccine
|
March 15, 2022
A novel chimeric dengue vaccine candidate composed of consensus envelope protein domain III fused to C-terminal-modified NS1 protein
Hong-Jyun Huang, Martyr Yang, Hsin-Wei Chen, et al.
Leukemia & Lymphoma
|
August 19, 2015
Phase 1 trial of carfilzomib (PR-171) in combination with vorinostat (SAHA) in patients with relapsed or refractory B-cell lymphomas
Beata Holkova, Maciej Kmieciak, Prithviraj Bose, et al.
Journal of Medical Virology
|
January 31, 2026
A Multivalent Dengue Fusion Protein ΔcNS1-cEDIII-ΔnNS3 Confers Cross-Serotype Protection and Durable Immunity in Mice
Mu-Fan Pi, Wei-Chiao Liao, Xin-Yan Li, et al.
Page
of 33